Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair DeficiencyÉric Bouffet, Uri Tabori, Roula Farah et al.|Journal of Clinical Oncology|2016Cited by 867
Comprehensive Analysis of Hypermutation in Human CancerBrittany Campbell, Melyssa Aronson, Nicholas Light et al.|Cell|2017Cited by 795
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastomaLinda M. Liau, Santosh Kesari, Keyoumars Ashkan et al.|Journal of Translational Medicine|2018Cited by 540
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent GlioblastomaLinda M. Liau, Lynne P. Taylor, Keyoumars Ashkan et al.|JAMA Oncology|2022Cited by 411
DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human CellsJiil Chung, Cynthia Hawkins, Yosef E. Maruvka et al.|Cancer Discovery|2020Cited by 85